Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Sep 2025.
- Yi Yun Tun Advanced Biotech has filed 1 Form D with the SEC, most recently Sep 2025 ( sold).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yi Yun Tun Advanced Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Yi Yun Tun Advanced Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yi Yun Tun Advanced Biotech
Developer of biomedical medicines intended for therapeutic and diagnostic purposes. The company offers laboratory-based testing infrastructure, research-driven methodologies, and adherence to regulatory frameworks, enabling healthcare professionals and biomedical researchers to access validated data, maintain compliance with statutory requirements, and support innovation in clinical and scientific applications through structured and reliable biotechnological practices.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2025
- Ownership
- Privately Held (backing)
Yi Yun Tun Advanced Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yi Yun Tun Advanced Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yi Yun Tun Advanced Biotech in its N-PORT filings yet. We sweep new filings monthly.